Cargando…
Limitations in Contemporary Pharmacological Stroke Prevention Therapies in Atrial Fibrillation: A Descriptive Literature Review
The most common arrhythmia, atrial fibrillation (AF), increases with age and is associated with a 5-fold increased risk of stroke. Although lifelong oral anticoagulation (OAC) is strongly recommended for stroke prevention in patients with AF and CHA(2)DS(2)-VASc ≥ 2 only 50–60% of patients in Wester...
Autores principales: | Garot, Philippe, Bergmann, Martin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607152/ https://www.ncbi.nlm.nih.gov/pubmed/37892737 http://dx.doi.org/10.3390/jcm12206594 |
Ejemplares similares
-
Non-Pharmacological Stroke Prevention in Atrial Fibrillation
por: Anduaga, Iñigo, et al.
Publicado: (2023) -
Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
por: Ueberham, Laura, et al.
Publicado: (2017) -
Update on the Non-Pharmacological Management of Stroke Prevention in Patients with Atrial Fibrillation
por: Tolat, Aneesh, et al.
Publicado: (2018) -
Optimal Choice of Pharmacological Therapy – Prevention of Stroke and Assessment of Bleeding Risk in Patients with Atrial Fibrillation
por: Hodzic, Enisa, et al.
Publicado: (2019) -
Stroke in atrial fibrillation: Review of risk stratification and preventive therapy
por: Alshehri, Abdullah M.
Publicado: (2019)